ANTIEMETIC EFFICACY AND PHARMACOKINETIC ANALYSES OF THE SEROTONIN ANTAGONIST ONDANSETRON (GR-38032F) DURING MULTIPLE-DAY CHEMOTHERAPY WITH CISPLATIN PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION

被引：28
作者：
LAZARUS, HM
BRYSON, JC
LEMON, E
PRITCHARD, JF
BLUMER, J
机构：
[1] UNIV HOSP CLEVELAND,IRELAND CANC CTR,DEPT PEDIAT,CLEVELAND,OH 44106
[2] UNIV HOSP CLEVELAND,IRELAND CANC CTR,DEPT PHARMACOL,CLEVELAND,OH 44106
[3] CASE WESTERN RESERVE UNIV,RAINBOW BABIES & CHILDRENS HOSP,CLEVELAND,OH 44106
[4] GLAXO INC,RES TRIANGLE PK,NC
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1990年 / 82卷 / 22期
关键词：
D O I：
10.1093/jnci/82.22.1776
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1776 / 1778
页数：3
相关论文
共 24 条
  • [1] ANTMAN K, 1987, CANCER TREAT REP, V71, P119
  • [2] BLACKWELL CP, 1989, EUR J CANCER CLIN ON, V25, pS21
  • [3] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE
    BRADLEY, PB
    ENGEL, G
    FENIUK, W
    FOZARD, JR
    HUMPHREY, PPA
    MIDDLEMISS, DN
    MYLECHARANE, EJ
    RICHARDSON, BP
    SAXENA, PR
    [J]. NEUROPHARMACOLOGY, 1986, 25 (06) : 563 - 576
  • [4] BRITTAIN R T, 1987, British Journal of Pharmacology, V90, p87P
  • [5] Bryson JC, 1988, P AN M AM SOC CLIN, V7, P69
  • [6] AUTOLOGOUS BONE-MARROW TRANSPLANTATION - CURRENT STATUS AND FUTURE-DIRECTIONS
    CHESON, BD
    LACERNA, L
    LEYLANDJONES, B
    SAROSY, G
    WITTES, RE
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (01) : 51 - 65
  • [7] CIOBANU N, 1989, P AN M AM SOC CLIN, V8, P281
  • [8] COLTHUP PV, 1989, EUR J CANCER CLIN ON, V25, pS71
  • [9] THE ENTERIC NEURAL RECEPTOR FOR 5-HYDROXYTRYPTAMINE
    GERSHON, MD
    TAKAKI, M
    TAMIR, H
    BRANCHEK, T
    [J]. EXPERIENTIA, 1985, 41 (07): : 863 - 868
  • [10] GR-38032F (GR-C507/75) - A NOVEL COMPOUND EFFECTIVE IN THE PREVENTION OF ACUTE CISPLATIN-INDUCED EMESIS
    HESKETH, PJ
    MURPHY, WK
    LESTER, EP
    GANDARA, DR
    KHOJASTEH, A
    TAPAZOGLOU, E
    SARTIANO, GP
    WHITE, DR
    WERNER, K
    CHUBB, JM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (06) : 700 - 705
123